Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Apr 29 2024

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 29, 2024, titled "Glenmark Pharmaceuticals receives ANDA approval forAcetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC)".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases